Microneedle Delivery for Peptides and Proteins

Evaluate formulation stability, biological activity, target dose, microneedle loading and delivery requirements for peptide- and protein-based programs.

Illustrative layered microneedle structure showing a payload-rich tip and structural matrix — Illustrative scientific visualization. Project-specific design and performance may vary.

Development Challenges

The payload and target product profile must be translated into a formulation, structure and process that preserve critical performance attributes.

Molecular Stability
Biological Activity
Target Dose
Polymer Compatibility

Key Development Questions

The assessment begins by defining the payload, target dose, intended use, release objective, available data and manufacturing constraints that shape the project pathway.

What We Evaluate

CASMN defines project-appropriate feasibility, formulation, mechanical, delivery, analytical and process studies.

Moisture and Temperature Sensitivity
Immediate or Sustained Release
Analytical Methods
Process Scale-Up

Relevant Microneedle Technologies

Technology selection depends on payload properties, dose, release requirements, intended use and manufacturing constraints.

Development Workflow

Non-confidential review → feasibility assessment → formulation and prototype development → analytical and performance evaluation → process development → pilot scale-up planning.

Published Research

Relevant CASMN team publications are used as scientific context. Published research does not by itself establish product approval, clinical performance or commercial readiness.

Feasibility and performance are project-specific and depend on payload properties, target dose, product design, analytical strategy and intended use. Technical Review — Reviewed by: CASMN R&D Team · Last reviewed: August 2026.

Related Technologies and Applications

Dissolving Microneedles→Coated Microneedles→

Frequently Asked Questions

How does CASMN assess application feasibility?

The team reviews payload properties, target dose, stability, intended use, delivery requirements and manufacturing constraints.

Which microneedle technology is most relevant?

Technology selection is made project by project after reviewing dose, release profile, product use and process requirements.

Is published research equivalent to an approved product?

No. Publications provide scientific context and do not establish regulatory approval, clinical performance or commercial availability.

Request an Application Assessment

Send your target product, payload, development stage and cooperation scope to our business development team.

Start a Project